TY - JOUR
T1 - Treatment selection for tonsillar squamous cell carcinoma
AU - Kuo, Yao Yuan
AU - Chu, Pen Yuan
AU - Chang, Shyue Yih
AU - Wang, Yi Fen
AU - Tsai, Tung Lung
AU - Yang, Muh Hwa
AU - Wang, Ling Wei
AU - Tai, Shyh Kuan
N1 - Funding Information:
This work was supported in part by the National Science Council of Taiwan (Grant No. NSC 98-2314-B-010-013-MY3 ) and Taipei Veterans General Hospital (grant nos. V100C-090 and V101C-057 ).
PY - 2013/4
Y1 - 2013/4
N2 - Background: The optimal treatment for tonsillar squamous cell carcinoma (SCC) remains controversial. The purpose of this study was to evaluate long-term treatment outcomes of patients with tonsillar SCC, in order to aid in appropriate treatment selection. Methods: We conducted a retrospective chart review of 105 patients with curatively treated tonsillar SCC between January 1996 and December 2005. Forty-three patients (41.0%) underwent primary surgery with or without adjuvant therapy (primary surgery group), and 62 patients (59.0%) were treated with radiotherapy/chemoradiotherapy (RT/CRT, organ preservation group). Twenty patients (19%) received tumor tonsillectomy before definitive RT/CRT and were grouped into the organ preservation group. Results: No significant differences were observed between the primary surgery and organ preservation groups in terms of local control (. p = 0.212), regional control (. p = 0.684), distant metastasis (. p = 0.627), 5-year disease-specific survival (DSS, p = 0.774), and overall survival rates (OS, p = 0.667). The rates of major complication (. p = 0.216), long-term dependency on feeding tubes (. p = 0.876), and tracheostomy (. p = 0.401) were also similar. Advanced T classification (T3-4) was the only factor associated with significantly worse DSS (. p = 0.007) and OS (. p = 0.012). However, there was also no difference in final treatment outcomes in T3-4 patients regardless of whether they were treated with primary surgery or RT/CRT. In the organ preservation group, tumor tonsillectomy before RT/CRT did not improve local control (. p = 0.520) or other treatment outcomes, including 5-year DSS (. p = 0.707) and OS (. p = 0.745). Conclusion: Both primary surgery and RT/CRT organ preservation are effective treatments for tonsillar SCC. Single modality treatment, either surgery or RT/CRT, can typically be provided for stage I-II diseases. Although RT/CRT organ preservation is used more frequently for stage III-IV tonsillar SCC in recent years, primary surgery combined with adjuvant therapy still achieves equivalent outcomes. Multidisciplinary pretreatment counseling and the facilities and personnel available are therefore important for decision-making. In addition, if RT/CRT organ preservation is selected as the primary treatment, tumor tonsillectomy is not indicated.
AB - Background: The optimal treatment for tonsillar squamous cell carcinoma (SCC) remains controversial. The purpose of this study was to evaluate long-term treatment outcomes of patients with tonsillar SCC, in order to aid in appropriate treatment selection. Methods: We conducted a retrospective chart review of 105 patients with curatively treated tonsillar SCC between January 1996 and December 2005. Forty-three patients (41.0%) underwent primary surgery with or without adjuvant therapy (primary surgery group), and 62 patients (59.0%) were treated with radiotherapy/chemoradiotherapy (RT/CRT, organ preservation group). Twenty patients (19%) received tumor tonsillectomy before definitive RT/CRT and were grouped into the organ preservation group. Results: No significant differences were observed between the primary surgery and organ preservation groups in terms of local control (. p = 0.212), regional control (. p = 0.684), distant metastasis (. p = 0.627), 5-year disease-specific survival (DSS, p = 0.774), and overall survival rates (OS, p = 0.667). The rates of major complication (. p = 0.216), long-term dependency on feeding tubes (. p = 0.876), and tracheostomy (. p = 0.401) were also similar. Advanced T classification (T3-4) was the only factor associated with significantly worse DSS (. p = 0.007) and OS (. p = 0.012). However, there was also no difference in final treatment outcomes in T3-4 patients regardless of whether they were treated with primary surgery or RT/CRT. In the organ preservation group, tumor tonsillectomy before RT/CRT did not improve local control (. p = 0.520) or other treatment outcomes, including 5-year DSS (. p = 0.707) and OS (. p = 0.745). Conclusion: Both primary surgery and RT/CRT organ preservation are effective treatments for tonsillar SCC. Single modality treatment, either surgery or RT/CRT, can typically be provided for stage I-II diseases. Although RT/CRT organ preservation is used more frequently for stage III-IV tonsillar SCC in recent years, primary surgery combined with adjuvant therapy still achieves equivalent outcomes. Multidisciplinary pretreatment counseling and the facilities and personnel available are therefore important for decision-making. In addition, if RT/CRT organ preservation is selected as the primary treatment, tumor tonsillectomy is not indicated.
KW - Organ preservation
KW - Squamous cell carcinoma
KW - Surgery
KW - Tonsil
KW - Tonsillectomy
UR - http://www.scopus.com/inward/record.url?scp=84875811009&partnerID=8YFLogxK
U2 - 10.1016/j.jcma.2012.12.007
DO - 10.1016/j.jcma.2012.12.007
M3 - Article
C2 - 23557888
AN - SCOPUS:84875811009
SN - 1726-4901
VL - 76
SP - 211
EP - 217
JO - Journal of the Chinese Medical Association
JF - Journal of the Chinese Medical Association
IS - 4
ER -